Ferritin Quantitative Test

SARS-CoV-2 Neutralizing Antibody Rapid Test

Biotime SARS-CoV-2 Neutralizing Antibody rapid test is a fluorescence immunoassay(FIA) for the qualitative detection of total neutralizing antibodies to SARS-CoV-2 in human serum or plasma. It is useful as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.

Product Detail

Product Features

Result in 10 min

Easy-to-use

High specificity and sensitivity

Room temperature storage

 

Product specification

Product Name

SARS-COV-2 Neutralizing Antibody Rapid Test

Sample Type 

Serum/Plasma

Loading Volume 

80 uL

Reaction Time

10 min

Interpretation of Results

Negative: <1.5 IU/mlPositive: 1.5 IU/ml

Shelf Life

24 months

Storage Condition

2-30℃

Unit

25 kits/box

 

Test Procedure 

1. Preparation: Take out one tube of buffer from refrigerator and balance it to room temperature.

2. Sampling For plasma/serum: Take 60μL of plasma or serum with a transfer pipette and add it to the buffer tube.  

3. Mixing: Mix well the specimen with buffer by tapping or inverting the tube.

4. Loading :Take 80μL of sample mixture and load it into the well of the test cartridge.

5. Testing: Ensure that there are no air bubbles. Immediately insert the test cartridge into analyzer and incubate for 10 minutes.

Leave A Message

Please provide us with the information below, and we'll contact you as soon as possible.

Related Products
SARS-CoV-2 IgG/IgM Rapid Test
SARS-CoV-2 IgG/IgM Rapid Qualitative Test
The Biotime SARS-CoV-2 IgG/IgM Rapid Qualitative Test is intended to qualify the SARS-CoV-2 IgG and IgM antibody in human plasma, serum or whole blood by colloidal gold immunochromatography assay. The test can be used as an aid detection to SARS-CoV-2 infection and thus caused COVID-19 disease.
SARS-CoV-2 Antigen Rapid Test
SARS-CoV-2 Antigen Rapid Qualitative Test
The SARS-CoV-2 Antigen Rapid Qualitative Test is a colloidal gold immunochromatography intended for the qualitative detection of nucleocapsid antigens from SARS-CoV-2 in human nasal swabs, throat swabs, and sputum from individuals who are suspected of COVID-19 by their healthcare provider. within the first five days of the onset of symptoms.
Rubella IgG/IgM Rapid Test (Fluorescence Immunoassay)
Rubella IgG/IgM Rapid Test (Fluorescence Immunoassay)
TheRubella IgG/IgM Rapid Test is an in vitro immunoassay for the in vitro qualitative determination of IgG and IgM class antibodies toRubella in human serum.IgG results with this assay are used to indicate past or recent infection withRubella. IgM results obtained with this assay are used as an aid in the diagnosis of acute or recent Rubella infections. Rubella IgM test shall not be used for prenatal screening of asymptomatic people, and the test results of this reagent shall not be used alone as the basis for termination of pregnancy.
MPV IgG/IgM Rapid Test
MPV IgG/IgM Rapid Test
The MPV IgG/IgM Rapid Test is a lateral flow chromatographic immunoassay for the qualitative detection and differentiation of IgM and IgG antibodies to Monkeypox Virus (MPV) in human serum, plasma, venous whole blood, or fingertip blood. It is intended for use as an aid in identifying individuals with an adaptive immune response to MPV, indicating recent or prior infection. At this time, it is unknown how long antibodies persist following infection and if the presence of antibodies confers protective immunity. The MPV IgG/IgM Rapid Test should not be used to diagnose acute MPV infection. For professional in vitro diagnostic use only.
Toxoplasma IgG/IgM Rapid Test (Fluorescence Immunoassay)
Toxoplasma IgG/IgM Rapid Test (Fluorescence Immunoassay)
TheToxoplasma IgG/IgM Rapid Test is an in vitro immunoassay for the in vitro qualitative determination of IgG and IgM class antibodies toToxoplasma gondii in human serum.IgG results with this assay are used to indicate past or recent infection withToxoplasma gondii. IgM results obtained with this assay are used as an aid in the diagnosis of acute or recentToxoplasma gondii infections. Toxoplasma IgM test shall not be used for prenatal screening of asymptomatic people, and the test results of this reagent shall not be used alone as the basis for termination of pregnancy. -Fluorescent immunoassay -Toxoplasma gondii infection -For in vitro diagnostic use only. For professional use only.
biotime fPSA Rapid Quantitative Test
fPSA Rapid Quantitative Test
PSA, a protein produced by prostate gland cells, circulates through the body in two ways: either bound to other proteins or on its own. PSA traveling alone is called free PSA. The free-PSA test measures the percentage of unbound PSA.
h-FABP Rapid Quantitative Test (Chemiluminescence Immunoassay)
h-FABP Rapid Quantitative Test (Chemiluminescence Immunoassay)
h-FABP Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the heart-type fatty acid binding protein (h-FABP) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of cardiac diseases.
biotime MAU Rapid Quantitative Test
MAU Rapid Quantitative Test
MAU(Microalbumin) occurs when the kidney leaks small amounts of albumin into the urine, which is an early marker of kidney damage.
Leave A Message

Leave A Message

    Please provide us with the information below, and we'll contact you as soon as possible.

Home

products

about

contact